Press Releases
Media Focus
QbD for biopharmaceutical product lifecycle management
Establishing an end-to-end drug life cycle that builds on Quality-by-Design (QbD) principles is important for CDMOs to develop and manufacture quality products.
Two of our QbD experts – Youngsun Kim and Busol Park – share key considerations for developing a QbD-led CDMO strategy that spans process characterization to commercial manufacturing.
Establishing an end-to-end drug life cycle that builds on Quality-by-Design (QbD) principles is important for CDMOs to develop and manufacture quality products.
Two of our QbD experts – Youngsun Kim and Busol Park – share key considerations for developing a QbD-led CDMO strategy that spans process characterization to commercial manufacturing.